Documente Academic
Documente Profesional
Documente Cultură
Abstract
Background. Epulides are the most frequently observed gingival tumours. The etiopathogenesis of the hyperpla
sia is not yet clear, and classification remains inconsistent.
Objectives. The aim of this study was to analyse clinicomorphological features of epulides
Material and Methods. The clinicomorphological investigations involved 150 patients with diagnoses of inflam
matory epulis (43), giant cell epulis (73), and fibrous epulis (34). The patients were allocated to three study and
four age subgroups. Medical history contained many detailed questions. Dental examination, Xrays and histopa
thological examination were all assessed.
Results. The incidence of fibrous epulides was significantly higher among patients aged 1544 years (29.4%) and
among those over the age of 60 (35.5%). Inflammatory epulides were most frequently diagnosed in patients aged
15 to 44 years and 45 to 60 years (41.9% and 44.2%, respectively). The occurrence of giant cell epulis was com
parable in all age groups (p = 0.0003). Recurrence was observed in 4 cases of fibrous, 4 cases of inflammatory and
3 cases of giant cell epulis. Multifocal disease was diagnosed in 3 patients with inflammatory epulides. Osteolysis
revealed on pantomograms was significantly more common in patients with giant cell epulis than those suffering
from inflammatory or fibrous lesions. In giant cell and fibrous epulides mean tumour size did not correlate with
osteoplasia whereas it did in the case of inflammatory epulides.
Conclusions. The variability of clinicomorphological features of epulides makes them a heterogenous group of
gingival tumours (Dent. Med. Probl. 2009, 46, 1, 1724).
Key words: epulides, clinical examination, histopatological examination.
Streszczenie
Wprowadzenie. Nadzilaki s najczciej obserwowanymi guzami dzise. Etiopatogeneza procesw rozrosto
wych dzise nie jest jeszcze wyjaniona, a klasyfikacja nieujednolicona.
Cel pracy. Analiza klinicznomorfologiczna nadzilakw
Materia i metody. Do klinicznomorfologicznego etapu bada zakwalifikowano 150 pacjentw z rozpoznanym
nadzilakiem zapalnym (43), nadzilakiem olbrzymiokomrkowym (73) i nadzilakiem wknistym (34). Pa
cjenci byli zakwalifikowani do trzech gwnych grup badawczych i 4 podgrup wiekowych. Wywiad zawiera wie
le szczegowych pyta. Przeprowadzono badanie stomatologiczne, radiologiczne i histopatologiczne.
Wyniki. Nadzilak wknisty statystycznie czciej pojawia si wrd pacjentw w wieku 1544 lat (29,4%)
i wrd pacjentw powyej 60. r.. (35,5%). Nadzilak zapalny statystycznie czciej wystpowa u pacjentw
w wieku 1544 lat i 4560 lat (41,9% i 44,2%). Nadzilak olbrzymiokomrkowy wystpowa porwnywalnie we
wszystkich grupach wiekowych (p = 0, 0003). Nawroty byy obserwowane w 4 przypadkach nadzilaka wkni
stego, 4 zapalnych i 3 olbrzymiokomrkowych. Wieloogniskowo odnotowano w 3 przypadkach nadzilaka za
palnego. Osteoliza kostna na pantomogramie statystycznie czciej wystpowaa w przebiegu nadzilaka olbrzy
miokomrkowego ni zapalnego czy wknistego. W nadzilaku olbrzymiokomrkowym i wknistym rozmiar
guza nie korelowa ze stwierdzan osteoplazj, podczas gdy stwierdzano tak zaleno w nadzilaku zapalnym.
Wnioski. Zrnicowane klinicznomorfologiczne badania nadzilakw mog pomc w stworzeniu heterogen
nych grup guzw dzisowych (Dent. Med. Probl. 2009, 46, 1, 1724).
Sowa kluczowe: nadzilaki, badanie kliniczne, badanie histopatologiczne.
18
I. NIEDZIELSKA, H. BORGIELMAREK
Histopathology
The study material consisted of histopatholog
ical specimens taken from study subjects (epulides
and squamous cell carcinoma) and retrieved from
Results
2 test was used in order to test the hypothesis;
statistical significanse was defined as p < 0.05.
A total of 150 epulides were diagnosed and
treated in the Department of Craniomaxillofacial
Surgery, Medical University of Silesia in
Katowice from 1998 through 2004. The pathology
was diagnosed in 89 women and 61 men and
included 43 inflammatory, 34 fibrous, and 73 giant
cell epulides.
The incidence of fibrous epulides was signifi
cantly higher among patients aged 1544 years
(29.4%) and among those over the age of 60
(35.5%). Inflammatory epulides were most fre
quently diagnosed in patients aged 15 to 44 years
and 45 to 60 years (41.9% and 44.2%, respective
ly). The occurrence of giant cell epulis was com
parable in all age groups (p = 0.0003) (Tab. 1)
Fibrous and giant cell epulides were signifi
cantly more frequent in posterior mandible (pre
molars and molars) whereas inflammatory
epulides were predominantly located in anterior
maxilla (p = 0.01).
Recurrence was observed in 4 cases of fibrous,
4 cases of inflammatory and 3 cases of giant cell
epulis. Multifocal disease was diagnosed in 3 pa
tients with inflammatory epulides. Osteolysis
revealed on pantomograms was significantly more
common in patients with giant cell epulis than
those suffering from inflammatory or fibrous
lesions (p = 0.02)
Stimulants, presence of other local or general
disease, and the resulting pharmacotherapy were
more commonly noted in patients with giant cell
Study
parameters
(Parametry
badania)
Fibrous
epulis (%)
(Nadzilak
wknisty)
Giant cell
epulis (%)
(Nadzilak
olbrzymio
komrkowy)
Inflammatory
epulis
(%)
(Nadzilak
zapalny)
Univariate
analysis 2
(Test 2)
Age
(Wiek)
15
1544
4560
> 60
3 (8.8)
10 (29.4)
9 (26.5)
12 (35.3)
20 (27.4)
13 (17.8)
21 (28.8)
19 (26.0)
1 (2.3)
18 (41.9)
19 (44.2)
5 (11.6)
p = 0.0003
Gender
(Pe)
female
male
20 (58.8)
14 (41.2)
39 (53.4)
34 (46.6)
30 (69.8)
13 (30.2)
ns. (p = 0.22)
Trauma
(Uraz)
no
yes
15 (44.1)
19 (55.9)
36 (49.3)
37 (50.7)
20 (46.5)
23 (53.5)
ns. (p = 0.87)
Hygiene
(Higiena jamy ustnej)
poor
good
19 (55.9)
15 (44.1)
33 (45.2)
40 (54.8)
22 (51.2)
21 (48.8)
ns. (p = 0.57)
Stimulants (coffee,
alcohol, tobacco)
(Czynniki pobudzajce:
kawa, alkohol, papierosy)
no
yes
24 (70.6)
10 (29.4)
48 (65.8)
25 (34.3)
38 (88.4)
5 (11.6)
p = 0.02
Inflammation
(Zapalenie)
no
yes
16 (47.1)
18 (52.9)
46 (63.0)
27 (37.0)
31 (72.1)
12 (27.9)
ns. (p = 0.08)
Medication
(Leki)
no
yes
18 (52.9)
16 (47.1)
56 (76.7)
17 (23.3)
34 (79.1)
9 (20.9)
p = 0.02
no
yes
18 (52.9)
16 (47.1)
57 (78.1)
16 (21.9)
34 (79.1)
9 (20.9)
p = 0.01
Ulceration
(Owrzodzenie)
no
yes
34 (100.0)
0
72 (98.6)
1 (1.4)
43 (100.0)
0
ns. (p = 0.99)
Bleeding
(Krwawienie)
no
yes
28 (82.4)
6 (17.7)
60 (82.2)
13 (17.8)
40 (93.0)
3 (7.0)
ns. (p = 0.20)
Pain (Bl)
no
yes
34 (100.0)
0
73 (100.0)
0
41 (95.4)
2 (4.6)
ns. (p = 0.08)
Period
(Okres)
up to 1 month
1 to 3 months
3 to 6 months
6 to 12 months
over 1 year
2 (5.9)
11 (32.4)
4 (11.8)
6 (17.7)
11 (32.4)
14 (20.0)
13 (18.6)
20 (28.6)
12 (17.1)
11 (15.7)
10 (24.4)
15 (36.6)
4 (9.8)
5 (12.2)
7 (17.1)
p = 0.02
Location
(Umiejscowienie)
anterior
maxilla
5 (15.2)
16 (22.9)
17 (42.5)
p = 0.01
posterior
maxilla
4 (12.1)
8 (11.4)
10 (25.0)
anterior
mandible
10 (30.3)
15 (21.4)
6 (15.0)
posterior
mandible
14 (42.4)
31 (44.3)
7 (17.5)
Osteolysis
(Osteoliza)
no
yes
32 (94.1)
2 (5.9)
45 (61.6)
28 (38.4)
29 (67.4)
14 (32.6)
p = 0.002
Recurrence
(Nawrt)
no
yes
30 (88.2)
4 (11.8)
70 (95.9)
3 (4.1)
39 (90.7)
4 (9.3)
ns. (p = 0.30)
Multifocal disease
(Wieloogniskowo)
no
yes
34 (100.0)
0
73 (100.0)
0
40 (93.0)
3 (7.0)
Treatment
(Leczenie)
removal
electrosurgery
tooth extraction
alveolar process
resection
recurrence
24
9
4
12
45
12
12
29
3
ns. (p = 0.40)
1
4
16
3
2
4
20
I. NIEDZIELSKA, H. BORGIELMAREK
Discussion
Epulides are gingival hyperplasias of yet
unknown etiology. The term epulis is of Greek ori
gin, meaning "on the gum", and thus strictly topo
Table 2. Pathological changes in peripheral giant cell granuloma; all age groups (n = 73)
Tabela 2. Zmiany patologiczne w obwodowych nadzilakach olbrzymiokomrkowych; wszystkie grupy wiekowe (n = 73)
I
( 15)
II
(1544)
III
(4560)
IV
(> 60)
Number of cases
(Liczba przypadkw)
20
13
21
19
Gender (Pe)
1.6
2.5
1.6
1.6
1.4
1.5
2.4
1.4
Mean (rednia)
1.9
1.6
1.5
1.9
Ulceration (Owrzodzenie)
9/20
10/13
10/21
13/19
Inflammation (Zapalenie)
acute (ostre)
chronic (przewleke)
acute/chronic (ostre/przewleke)
4
8
4
0
5
12
1
8
3
1
7
2
13/20
10/13
11/21
10/19
Giant cells
(Komrki olbrzymie)
+
++
+++
8
9
3
2
9
3
6
8
7
4
8
7
Fibrosis (Wknienie)
peripheral
lobar
11/20
4/20
4/13
7/13
8/21
10/21
6/19
4/19
Hemosiderin (Hemosyderyna)
10/20
8/13
13/21
11/19
Osteoplasia (Osteoplazja)
4/20
8/13
7/21
5/19
Dystrophic calcification
(Zwapnienie dystroficzne)
3/20
2/13
3/21
2/19
Epithelial hyperplasia
(Rozrost nabonka)
21
Epulides
Number of cases
(Liczba przypadkw)
I
( 15)
II
(1544)
III
(4560)
IV
(> 60)
18
19
Gender (Pe)
0.7
1.3
1.5
1.4
1.5
2.5
1.3
Mean (rednia)
0.7
1.4
1.4
1.8
Ulceration (Owrzodzenie)
1/1
17/18
18/19
5/5
Plasmocytes (Plazmocyty)
+++
++
+
8
3
2
8
1
1
1
1
1
Granulocytes (Granulocyty)
+++
++
+
3
5
2
4
7
2
3
1
Leukocytes (Leukocyty)
+++
++
+
1
2
14
3
16
Macrophages (Makrofagi)
Granulation (Ziarninowanie)
1/1
16/18
19/19
5/5
4
12
2
4
11
2
2
1
Fibrosis (Wknienie)
+++
++
+
1
7
1
8
1
3
Hemosiderin (Hemosyderyna)
Osteoplasia (Osteoplazja)
6/18
8/19
5/5
Dystrophic calcification
(Wapnienie dystroficzne)
2/18
4/19
2/5
22
I. NIEDZIELSKA, H. BORGIELMAREK
II
(1544)
III
(4560)
IV
(> 60)
Number of cases
(Liczba przypadkw)
18
19
Gender (Pe)
0.4
1.3
1.5
1.4
1.5
2.5
1.3
Mean (rednia)
0.5
1.2
1.4
2.4
Ulceration (Owrzodzenie)
2/3
3/10
1/9
5/5
Plasmocytes (Plazmocyty)
+++
++
+
1
1
2
3
1
1
1
3
2
1
Granulocytes (Granulocyty)
++
+
3
1
Leukocytes (Leukocyty)
+++
++
+
1
2
7
1
4
4
11
Granulation (Ziarninowanie)
1/3
3/10
2/19
1/12
3
4
1
4
3
3
3
1
Fibrosis (Wknienie)
+++
++
+
3
7
4
5
1
3
7
3
Hemosiderin (Hemosyderyna)
Osteoplasia (Osteoplazja)
Dystrophic calcification
(Wapnienie dystroficzne)
Epulides
23
phagephagocyte system or osteoclast differentia
tion [22]. Apart from myofibroblasts, stromal
compartment of the granuloma also contained
mastocytes; however, no differentiation into
tryptase and chymasepositive mastocytes was
carried out [23]. Mighell et al. [24] showed the
absence of elastic fibres.
Attempts were undertaken to evaluate the bio
chemistry of epulides including polyamines. They
may bind to DNA, RNA, and histones; their acety
lation may play an important role in cell growth.
The etiology of epulides poses problems. Some
authors hypothesized that periodontal fibres irrita
tion might be the cause [25, 26]; calcification and
ossification were frequently observed in fibrous
epulis [27]. However, others negated the concept.
Our own investigations revealed few cases of dys
trophic calcifications in all epulis subclasses.
Authors concluded that the variability of clin
icomorphological features of epulides makes them
a heterogenous group of gingival tumours.
References
[1] PAMMER J., WENINGER W., HULLA H., MAZAL P., HORVAT R.: Expression of regulatory apoptotic proteins in
peripheral giant cell granulomas and lesions containing osteoclastlike giant cells. J. Oral Pathol. Med. 1998, 27,
267271.
[2] AXHAUSEN G.: Die Allgemeine Chirurgie in der ZahnMund und Kieferheilkunde, J.T. Lehmann. MunchenBerlin
1940.
[3] BERNABEI P., COCCIA E.M., RIGAMONTI L., BOSTICARDO M., FORNI G., PESTKA S., KRAUSE C.D., BATTISTINI A.,
NOVELLI F.: Interferongamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell pro
liferation or death. Leukoc. Biol. 2001, 70, 950960.
[4] BRODERS A.C.: Carcinoma grading and practical application. Arch. Pathol. 1976, 2, 376381
[5] COOKE B.E.D.: The fibrous epulis and the fibroepithelial polyp: their histogenesis and natural history. Br. Dent. J.
1952, 93, 305.
[6] LANGAAS V., SHAHZIDI S., JOHNSEN J.I., SMEDSROD B., SVEINBJORNSSON B. Interferongamma modulates TRAIL
mediated apoptosis in human colon carcinoma cells. Anticancer Res. 2001, 21, 37333738.
[7] BERNIER J.L., CAHN L.R.: Peripheral giant cell reparative granuloma. J. Am. Dent. Assoc 1954, 49, 141.
[8] SASAGAWA T., HLAING M., AKAIKE T.: Synergistic induction of apoptosis in murine hepatoma Hepa16 cells by
IFNgamma and TNFalpha. Biochem. Biophys. Res. Commun. 2000, 272, 674680.
[9] FRIESEL R, KOMORIYA A, MACIAG T.: Inhibition of endothelial cell proliferation by gammainterferon. J. Cell Biol.
1987, 104, 689696.
[10] BERNIER J.L., CAHN L.R.: Peripheral giant cell reparative granuloma. J. Am. Dent. Assoc. 1954, 49, 141.
[11] KIUCHI N, NAKAJIMA K, ICHIBA M, FUKADA T, NARIMATSU M, MIZUNO K, HIBI M, HIRANO T. STAT3 is required
for the gp130mediated full activation of the cmyc gene. J. Exp. Med. 1999, 189, 6373.
[12] TANAKA N., KAWAKAMI T., TANIGUCHI T.: Recognition DNA sequences of interferon regulatory factor 1 (IRF1)
and IRF2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 1993, 13, 45314538.
[13] GUO Y., SRINIVASULA S.M., DRUILHE A., FERNANDESALNEMRI T., ALNEMRI E.S.: Caspase2 induces apoptosis by
releasing proapoptotic proteins from mitochondria. J. Biol. Chem. 2002, 277, 1343013433.
[14] BLUYSSEN A.R., DURBIN J.E., LEVY D.E.: ISGF3 gamma p48, a specificity switch for interferon activated tran
scription factors. Cytokine Growth Factor Rev. 1996, 7, 1117.
[15] KALVAKOLANU D.V.: Alternate interferon signaling pathways. Pharmacol. Ther. 2003, 100, 129.
[16] PESTKA S., KOTENKO S.V., MUTHUKUMARAN G., IZOTOVA L.S., COOK J.R., GAROTTA G.: The interferon gamma
(IFNgamma) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 1997, 8,
189206.
[17] EVERSOLE L. R., ROVIN S.: Diagnosis of gingival tumefactions. Periodontology 1973, 44, 485.
[18] MCDONNELL T.J., TRONCOSO P., BRISBAY S.M., LOGOTHETIS C. H., CHUNG L.W.K., HSIEH J.T., TU S.M., CAMBELL
M.L: Expression of the protooncogene bcl2 in the prostate and its association with emergence of androgeninde
pendent prostate cancer. Cancer Res. 1992, 52, 69406944.
24
I. NIEDZIELSKA, H. BORGIELMAREK
[19] TARTAGLIA L.A., GOEDDEL D.V., REYNOLDS C., FIGARI I.S., WEBER R.F., FENDLY B.M., PALLADINO M.A. JR.:
Stimulation of human Tcell proliferation by specific activation of the 75kDa tumor necrosis factor receptor.
J. Immunol. 1993, 151, 46374641.
[20] CALIFANO J., WESTRA W.H., MEININGER G., CORIO R., KOCH W.M., SIDRANSKY D.F.: Genetic progression and clon
al relationship of reccurent premalignant head and neck lession. Clin. Cancer Res. 2000, 6, 347.
[21] RAMDIAL P.K., MADAREE A., REDDY R., CHETTY R.: bcl2 protein expression in aggressive and nonaggressive
basal cell carcinomas. Oral Oncol. 1999, 35, 314320.
[22] DAHL E.C., RHYNE R.R., CORRELL R.W., CRAIG R.M.: Exophytic lesion of the maxillary gingiva. JADA 1981, 102,
6263.
[23] MARTINEZLARA I., GONZALEZMOLES M.A., RUIZAVILA I., BRAVO M., RAMOS M.C., FERNANDEZMARTINEZ J.A.:
Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa. Acta Stomatol. Belg. 1996, 93,
2932.
[24] MCGOWAN D.A.: Central giant cell tumor of mandible occuring in pregnancy. Br. J. Oral Surg. 1979, 17, 4346.
[25] MERLIN G., VAN DER LEEDE B.J., MCKUNE K., KNEZEVIC N., BANNWARTH W., ROMQUIN N., VIEGASPEQUIGNOT E.,
KIEFER H., AGUET M., DEMBIC Z.: The gene for the ligand binding chain of the human interferon gamma recep
tor. Immunogenetics 1997, 45, 413421.
[26] DARNELL J.E. JR, KERR I.M., STARK G.R. JakSTAT pathways and transcriptional activation in response to IFNs
and other extracellular signaling proteins. Science. 1994, 264, 14151421.
[27] LORO L.L., JOHANNESSEN A.C., VINTERMYR O.K., ZHONGHUA KOU QIANG YI XUE ZA ZHI: Decreased expression
of bcl2 in moderate and severe oral epithelia dysplasias. 2002, 37, 6568.
[28] LORO L.L., VINTERMYR O.K., LIAVAAG P.G., JONSSON R., JOHANNESSEN A.C.: Oral squamous cell carcinoma is
associated with decreased bcl2/bax expression ratio and increased apoptosis. Oral Oncol. 2002, 38, 691698.